Science Feb 11 The future of genetically modified mosquitoes could be in mini, moveable labs By Lev Facher, STAT
Health Mar 18 A pricey drug cuts cardiovascular risks in clinical trial — but will insurers cover it? Amgen's cholesterol drug lowered risk of cardiovascular trouble in a huge clinical trial — but the results may not be good enough for insurers to cover. By Damian Garde, STAT
Economy Apr 11 Watch Has the market rally in biotech and Internet stocks hit a wall? By PBS News Hour
Jun 10 Watch When Does Genetic Modification of Animals Cross a Line? When Does Genetic Modification of Animals Cross a Line?…
Science Mar 19 Watch Tiny Technology Holds Big Economic Potential In the latest in a series of reports making sense of the economy, economics correspondent Paul Solman examines the small scale of nanosciences and the big impact they could have on the economy.
May 29 Watch Venture Capitalists Look to Green Businesses for Boom A recent surge in investments by venture capitalists in eco-friendly businesses is possibly triggering a boom in green and clean technology. Analysts report on the green market and its ability to make money while saving oil. Continue watching